Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1307786

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1307786

APAC Drug modeling software Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 266 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Asia-Pacific drug modeling software market is expected to reach USD 1,999.99 million by 2030 from USD 1,085.16 million in 2022, growing at a CAGR of 8.2% during the forecast period of 2023 to 2033.

Market Segmentation:

Asia-Pacific Drug Modeling Software Market, By Component (Software, and Services), Operating System (Windows, Linux, Mac OS, and Others), Deployment Mode (Cloud Based, Hybrid Based, and On Premises), Enterprise Size(Large Enterprise Size, Small and Medium Enterprise Size), Application (Graphical Molecular Modeling, Gene Sequence Analysis, Protein Modeling, Modeling Crystal Structures, Cheminformatics, High Throughput Virtual Screening, Gas and Solution Phase Reaction, Medical Imaging, and Others), Purchase Model (Subscription Based, and One- Time License), End User( Pharmaceutical and Biotechnology Companies, Contract Research Organization, Research Institutes, Regulatory Authorities, and Others), Country (China, Japan , South Korea , India , Australia , Singapore, Thailand , Indonesia , Philippines , Malaysia , New Zealand , Vietnam , Taiwan, Rest Of Asia-Pacific) - Industry Trends and Forecast to 2030.

Overview of Asia-Pacific Drug Modeling Software Market Dynamics :

  • Driver
  • Rising drug discovery and development activities
  • Restrain
  • Lack of quality data base
  • Opportunity
  • Cloud computing and big data analytics in drug modelling

Market Players:

The key market players operating in the Asia-Pacific drug modeling software market are listed below:

  • Dassault Systemes
  • Amazon Web Services, Inc.
  • Certara, USA.
  • Schrodinger, Inc.
  • Cresset.
  • SIMULATIONS PLUS.
  • Others

TABLE OF CONTENTS

1 INTRODUCTION 57

  • 1.1 OBJECTIVES OF THE STUDY 57
  • 1.2 MARKET DEFINITION 57
  • 1.3 OVERVIEW OF THE ASIA PACIFIC DRUG MODELING SOFTWARE MARKET 57
  • 1.4 CURRENCY AND PRICING 59
  • 1.5 LIMITATIONS 59
  • 1.6 MARKETS COVERED 59

2 MARKET SEGMENTATION 62

  • 2.1 MARKETS COVERED 62
  • 2.2 GEOGRAPHICAL SCOPE 63
  • 2.3 YEARS CONSIDERED FOR THE STUDY 64
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 65
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 68
  • 2.6 MULTIVARIATE MODELING 69
  • 2.7 COMPONENT LIFELINE CURVE 69
  • 2.8 DBMR MARKET POSITION GRID 70
  • 2.9 VENDOR SHARE ANALYSIS 71
  • 2.10 MARKET APPLICATION COVERAGE GRID 72
  • 2.11 SECONDARY SOURCES 73
  • 2.12 ASSUMPTIONS 73

3 EXECUTIVE SUMMARY 74

  • 3.1 PORTER'S FIVE FORCES MODEL 78
  • 3.2 VALUE CHAIN ANALYSIS 79
  • 3.3 REGULATORY STANDARDS 80
  • 3.4 TECHNOLOGICAL TRENDS 81
  • 3.5 BENEFITS OF DRUG MODELING SOFTWARE 82

4 MARKET OVERVIEW 83

  • 4.1 DRIVERS 85
    • 4.1.1 RISING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 85
    • 4.1.2 RISING DEMAND FOR NOVEL THERAPIES 87
    • 4.1.3 PRECISION MEDICINE AND INTERVENTION OF AI IN DRUG MODELLING 88
  • 4.2 RESTRAINTS 89
    • 4.2.1 LACK OF QUALITY DATA BASE 89
    • 4.2.2 HIGH COST OF MANUFACTURING OF DRUG MODELLING SOFTWARE 89
  • 4.3 OPPORTUNITIES 90
    • 4.3.1 CLOUD COMPUTING AND BIG DATA ANALYTICS IN DRUG MODELLING 90
    • 4.3.2 INCREASING ADOPTION OF MODELLING TOOLS IN DRUG DISCOVERY 91
  • 4.4 CHALLENGES 91
    • 4.4.1 LACK OF PROCEDURE FOR MULTI-DRUG EFFECT ASSESMENT 91
    • 4.4.2 CHALLENGES WITH MODEL INTERPRETATION 92

5 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY COMPONENTS 93

  • 5.1 OVERVIEW 94
    • 5.1.1 SOFTWARE 97
      • 5.1.1.1 INTEGRATED 98
      • 5.1.1.2 STANDALONE 98
      • 5.1.1.3 LIGAND BASED 98
      • 5.1.1.4 STRUCTURE BASED 98
  • 5.2 SERVICES 98
    • 5.2.1 PROFESSIONAL SERVICES 99
      • 5.2.1.1 CONSULTING AND TRAINING 100
      • 5.2.1.2 INTEGRATION AND IMPLEMENTATION 100
      • 5.2.1.3 SUPPORT AND MAINTENANCE 100
    • 5.2.2 MANAGED SERVICES 100

6 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM 101

  • 6.1 OVERVIEW 102
  • 6.2 WINDOWS 105
  • 6.3 LINUX 105
  • 6.4 MAC OS 106
  • 6.5 OTHERS 107

7 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE 108

  • 7.1 OVERVIEW 109
  • 7.2 CLOUD BASED 112
  • 7.3 HYBRID-BASED 112
  • 7.4 ON-PREMISES 113

8 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE 114

  • 8.1 OVERVIEW 115
  • 8.2 LARGE ENTERPRISE SIZE 118
  • 8.3 SMALL & MEDIUM ENTERPRISE SIZE 118

9 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY APPLICATION 120

  • 9.1 OVERVIEW 121
  • 9.2 GRAPHICAL MOLECULAR MODELING 124
  • 9.3 GENE SEQUENCE ANALYSIS 124
  • 9.4 PROTEIN MODELING 125
  • 9.5 MODELING CRYSTAL STRUCTURES 126
  • 9.6 CHEMINFORMATICS 127
  • 9.7 HIGH THROUGHPUT VIRTUAL SCREENING 128
  • 9.8 GAS & SOLUTION PHASE REACTION 128
  • 9.9 MEDICAL IMAGING 129
  • 9.10 OTHERS 130

10 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL 131

  • 10.1 OVERVIEW 132
  • 10.2 SUBSCRIPTION BASED 135
    • 10.2.1 ANNUALLY SUBSCRIPTION 136
    • 10.2.2 MONTHLY SUBSCRIPTION 136
  • 10.3 ONE-TIME LICENSE 136
    • 10.3.1 GROUP LICENSE 137
    • 10.3.2 DESKTOP LICENSE 137
    • 10.3.3 OTHERS 137

11 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY END USER 138

  • 11.1 OVERVIEW 139
  • 11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 142
    • 11.2.1 LARGE ENTERPRISE SIZE 143
    • 11.2.2 SMALL & MEDIUM ENTERPRISE SIZE 143
  • 11.3 CONTRACT RESEARCH ORGANIZATIONS 143
    • 11.3.1 LARGE ENTERPRISE SIZE 144
    • 11.3.2 SMALL & MEDIUM ENTERPRISE SIZE 144
  • 11.4 RESEARCH INSTITUTES 144
    • 11.4.1 LARGE ENTERPRISE SIZE 145
    • 11.4.2 SMALL & MEDIUM ENTERPRISE SIZE 145
  • 11.5 REGULATORY AUTHORITIES 145
    • 11.5.1 LARGE ENTERPRISE SIZE 146
    • 11.5.2 SMALL & MEDIUM ENTERPRISE SIZE 147
  • 11.6 OTHERS 147
    • 11.6.1 LARGE ENTERPRISE SIZE 148
    • 11.6.2 SMALL & MEDIUM ENTERPRISE SIZE 148

12 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY REGION 149

  • 12.1 ASIA-PACIFIC 150
    • 12.1.1 CHINA 161
    • 12.1.2 JAPAN 166
    • 12.1.3 SOUTH KOREA 171
    • 12.1.4 INDIA 176
    • 12.1.5 AUSTRALIA 181
    • 12.1.6 SINGAPORE 186
    • 12.1.7 THAILAND 191
    • 12.1.8 INDONESIA 196
    • 12.1.9 PHILIPPINES 201
    • 12.1.10 MALAYSIA 206
    • 12.1.11 NEW ZEALAND 211
    • 12.1.12 VIETNAM 216
    • 12.1.13 TAIWAN 221
    • 12.1.14 REST OF ASIA-PACIFIC 226

13 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: COMPANY LANDSCAPE 227

  • 13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 227

14 SWOT ANALYSIS 228

15 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, COMPANY PROFILE 229

  • 15.1 DASSAULT SYSTEMES 229
    • 15.1.1 COMPANY SNAPSHOT 229
    • 15.1.2 REVENUE ANALYSIS 229
    • 15.1.3 COMPANY SHARE ANALYSIS 230
    • 15.1.4 PRODUCT PORTFOLIO 230
    • 15.1.5 RECENT DEVELOPMENT 230
  • 15.2 AMAZON WEB SERVICES, INC. OR ITS AFFILIATES.(A SUBSIDIARY OF AMAZON) 231
    • 15.2.1 COMPANY SNAPSHOT 231
    • 15.2.2 REVENUE ANALYSIS 231
    • 15.2.3 COMPANY SHARE ANALYSIS 232
    • 15.2.4 PRODUCT PORTFOLIO 232
    • 15.2.5 RECENT DEVELOPMENTS 232
  • 15.3 CERTARA, USA. 233
    • 15.3.1 COMPANY SNAPSHOT 233
    • 15.3.2 REVENUE ANALYSIS 233
    • 15.3.3 COMPANY SHARE ANALYSIS 234
    • 15.3.4 PRODUCT PORTFOLIO 234
    • 15.3.5 RECENT DEVELOPMENTS 234
  • 15.4 SCHRODINGER, INC. 235
    • 15.4.1 COMPANY SNAPSHOT 235
    • 15.4.2 REVENUE ANALYSIS 235
    • 15.4.3 COMPANY SHARE ANALYSIS 236
    • 15.4.4 PRODUCT PORTFOLIO 236
    • 15.4.5 RECENT DEVELOPMENT 236
  • 15.5 CRESSET. 237
    • 15.5.1 COMPANY SNAPSHOT 237
    • 15.5.2 COMPANY SHARE ANALYSIS 237
    • 15.5.3 PRODUCT PORTFOLIO 238
    • 15.5.4 RECENT DEVELOPMENTS 238
  • 15.6 ACELLERA LTD 239
    • 15.6.1 COMPANY SNAPSHOT 239
    • 15.6.2 PRODUCT PORTFOLIO 239
    • 15.6.3 RECENT DEVELOPMENTS 239
  • 15.7 ARGUSLAB 240
    • 15.7.1 COMPANY SNAPSHOT 240
    • 15.7.2 PRODUCT PORTFOLIO 240
    • 15.7.3 RECENT DEVELOPMENT 240
  • 15.8 ATOMWISE INC. 241
    • 15.8.1 COMPANY SNAPSHOT 241
    • 15.8.2 PRODUCT PORTFOLIO 241
    • 15.8.3 RECENT DEVELOPMENT 241
  • 15.9 BC PLATFORMS 242
    • 15.9.1 COMPANY SNAPSHOT 242
    • 15.9.2 PRODUCT PORTFOLIO 242
    • 15.9.3 RECENT DEVELOPMENTS 243
  • 15.10 BIOSOLVEIT GMBH 244
    • 15.10.1 COMPANY SNAPSHOT 244
    • 15.10.2 PRODUCT PORTFOLIO 244
    • 15.10.3 RECENT DEVELOPMENT 244
  • 15.11 DOTMATICS 245
    • 15.11.1 COMPANY SNAPSHOT 245
    • 15.11.2 PRODUCT PORTFOLIO 245
    • 15.11.3 RECENT DEVELOPMENTS 246
  • 15.12 GENECODE 247
    • 15.12.1 COMPANY SNAPSHOT 247
    • 15.12.2 PRODUCT PORTFOLIO 247
    • 15.12.3 RECENT DEVELOPMENT 247
  • 15.13 INSILICOTRIALS TECHNOLOGIES. 248
    • 15.13.1 COMPANY SNAPSHOT 248
    • 15.13.2 PRODUCT PORTFOLIO 248
    • 15.13.3 RECENT DEVELOPMENTS 249
  • 15.14 NANOME INC. 250
    • 15.14.1 COMPANY SNAPSHOT 250
    • 15.14.2 PRODUCT PORTFOLIO 250
    • 15.14.3 RECENT DEVELOPMENT 250
  • 15.15 OPTIBRIUM, LTD. 251
    • 15.15.1 COMPANY SNAPSHOT 251
    • 15.15.2 PRODUCT PORTFOLIO 251
    • 15.15.3 RECENT DEVELOPMENT 251
  • 15.16 PHARMACELERA 252
    • 15.16.1 COMPANY SNAPSHOT 252
    • 15.16.2 PRODUCT PORTFOLIO 252
    • 15.16.3 RECENT DEVELOPMENT 252
  • 15.17 SIMULATIONS PLUS. 253
    • 15.17.1 COMPANY SNAPSHOT 253
    • 15.17.2 REVENUE ANALYSIS 254
    • 15.17.3 COMPANY SHARE ANALYSIS 255
    • 15.17.4 PRODUCT PORTFOLIO 255
    • 15.17.5 RECENT DEVELOPMENT 256
  • 15.18 THE SCRIPPS RESEARCH INSTITUTE 257
    • 15.18.1 COMPANY SNAPSHOT 257
    • 15.18.2 PRODUCT PORTFOLIO 257
    • 15.18.3 RECENT DEVELOPMENT 257
  • 15.19 VERISIM LIFE. 258
    • 15.19.1 COMPANY SNAPSHOT 258
    • 15.19.2 PRODUCT PORTFOLIO 258
    • 15.19.3 RECENT DEVELOPMENTS 258
  • 15.20 XTALPI INC. 259
    • 15.20.1 COMPANY SNAPSHOT 259
    • 15.20.2 PRODUCT PORTFOLIO 259
    • 15.20.3 RECENT DEVELOPMENT 259
  • 15.21 XYBION DIGITAL INC. 260
    • 15.21.1 COMPANY SNAPSHOT 260
    • 15.21.2 REVENUE ANALYSIS 260
    • 15.21.3 PRODUCT PORTFOLIO 261
    • 15.21.4 RECENT DEVELOPMENT 261

16 QUESTIONNAIRE 262

17 RELATED REPORTS 266

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 67
  • TABLE 2 ASIA PACIFIC SOFTAWARE IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 68
  • TABLE 3 ASIA PACIFIC SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
  • TABLE 4 ASIA PACIFIC SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 69
  • TABLE 5 ASIA PACIFIC SERVICES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 70
  • TABLE 6 ASIA PACIFIC SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 70
  • TABLE 7 ASIA PACIFIC PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 71
  • TABLE 8 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 75
  • TABLE 9 ASIA PACIFIC WINDOWS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 76
  • TABLE 10 ASIA PACIFIC LINUX IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 77
  • TABLE 11 ASIA PACIFIC MAC OS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 77
  • TABLE 12 ASIA PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 78
  • TABLE 13 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 82
  • TABLE 14 ASIA PACIFIC CLOUD BASED IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 83
  • TABLE 15 ASIA PACIFIC HYBRID-BASED IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 84
  • TABLE 16 ASIA PACIFIC ON-PREMISES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 84
  • TABLE 17 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 88
  • TABLE 18 ASIA PACIFIC LARGE ENTERPRISE SIZE IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 89
  • TABLE 19 ASIA PACIFIC SMALL & MEDIUM ENTERPRISE SIZE IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 90
  • TABLE 20 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 94
  • TABLE 21 ASIA PACIFIC GRAPHICAL MOLECULAR MODELING IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 95
  • TABLE 22 ASIA PACIFIC GENE SEQUENCE ANALYSIS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 96
  • TABLE 23 ASIA PACIFIC PROTEIN MODELING IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 97
  • TABLE 24 ASIA PACIFIC MODELING CRYSTAL STRUCTURES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 98
  • TABLE 25 ASIA PACIFIC CHEMINFORMATICS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 98
  • TABLE 26 ASIA PACIFIC HIGH THROUGHPUT VIRTUAL SCREENING IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 99
  • TABLE 27 ASIA PACIFIC GAS & SOLUTION PHASE REACTION IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 100
  • TABLE 28 ASIA PACIFIC MEDICAL IMAGING IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 101
  • TABLE 29 ASIA PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 101
  • TABLE 30 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 105
  • TABLE 31 ASIA PACIFIC SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 106
  • TABLE 32 ASIA PACIFIC SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 106
  • TABLE 33 ASIA PACIFIC ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 107
  • TABLE 34 ASIA PACIFIC ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 108
  • TABLE 35 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 112
  • TABLE 36 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 113
  • TABLE 37 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 113
  • TABLE 38 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 114
  • TABLE 39 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 115
  • TABLE 40 ASIA PACIFIC RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 41 ASIA PACIFIC RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 116
  • TABLE 42 ASIA PACIFIC REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 117
  • TABLE 43 ASIA PACIFIC REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 117
  • TABLE 44 ASIA PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY REGION, 2021-2030 (USD MILLION) 118
  • TABLE 45 ASIA PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 118
  • TABLE 46 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 126
  • TABLE 47 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 126
  • TABLE 48 ASIA-PACIFIC SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 49 ASIA-PACIFIC SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 50 ASIA-PACIFIC SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 51 ASIA-PACIFIC PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 52 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 127
  • TABLE 53 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 128
  • TABLE 54 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 128
  • TABLE 55 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 128
  • TABLE 56 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 129
  • TABLE 57 ASIA-PACIFIC SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 129
  • TABLE 58 ASIA-PACIFIC ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 129
  • TABLE 59 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 129
  • TABLE 60 ASIA-PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 130
  • TABLE 61 ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 130
  • TABLE 62 ASIA-PACIFIC RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 130
  • TABLE 63 ASIA-PACIFIC REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 130
  • TABLE 64 ASIA-PACIFIC OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 131
  • TABLE 65 CHINA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 132
  • TABLE 66 CHINA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 67 CHINA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 68 CHINA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 69 CHINA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 133
  • TABLE 70 CHINA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 133
  • TABLE 71 CHINA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 133
  • TABLE 72 CHINA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 133
  • TABLE 73 CHINA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 134
  • TABLE 74 CHINA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 134
  • TABLE 75 CHINA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 134
  • TABLE 76 CHINA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 135
  • TABLE 77 CHINA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 135
  • TABLE 78 CHINA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 135
  • TABLE 79 CHINA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 135
  • TABLE 80 CHINA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 136
  • TABLE 81 CHINA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 136
  • TABLE 82 CHINA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 136
  • TABLE 83 JAPAN DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 137
  • TABLE 84 JAPAN SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 85 JAPAN SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 86 JAPAN SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 87 JAPAN PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 138
  • TABLE 88 JAPAN DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 138
  • TABLE 89 JAPAN DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 138
  • TABLE 90 JAPAN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 138
  • TABLE 91 JAPAN DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 139
  • TABLE 92 JAPAN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 139
  • TABLE 93 JAPAN SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 139
  • TABLE 94 JAPAN ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 140
  • TABLE 95 JAPAN DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 140
  • TABLE 96 JAPAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 140
  • TABLE 97 JAPAN CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 140
  • TABLE 98 JAPAN RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 141
  • TABLE 99 JAPAN REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 141
  • TABLE 100 JAPAN OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 141
  • TABLE 101 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 142
  • TABLE 102 SOUTH KOREA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 103 SOUTH KOREA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 104 SOUTH KOREA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 105 SOUTH KOREA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 106 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 143
  • TABLE 107 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 143
  • TABLE 108 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 143
  • TABLE 109 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 144
  • TABLE 110 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 144
  • TABLE 111 SOUTH KOREA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 144
  • TABLE 112 SOUTH KOREA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 145
  • TABLE 113 SOUTH KOREA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 145
  • TABLE 114 SOUTH KOREA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 145
  • TABLE 115 SOUTH KOREA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 146
  • TABLE 116 SOUTH KOREA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 146
  • TABLE 117 SOUTH KOREA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 146
  • TABLE 118 SOUTH KOREA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 146
  • TABLE 119 INDIA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 147
  • TABLE 120 INDIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 121 INDIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 122 INDIA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 123 INDIA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 124 INDIA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 148
  • TABLE 125 INDIA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 148
  • TABLE 126 INDIA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 148
  • TABLE 127 INDIA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 149
  • TABLE 128 INDIA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 149
  • TABLE 129 INDIA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 149
  • TABLE 130 INDIA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 150
  • TABLE 131 INDIA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 150
  • TABLE 132 INDIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 150
  • TABLE 133 INDIA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 150
  • TABLE 134 INDIA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 151
  • TABLE 135 INDIA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 151
  • TABLE 136 INDIA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 151
  • TABLE 137 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 152
  • TABLE 138 AUSTRALIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 139 AUSTRALIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 140 AUSTRALIA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 141 AUSTRALIA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 142 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 153
  • TABLE 143 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 153
  • TABLE 144 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 153
  • TABLE 145 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 154
  • TABLE 146 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 154
  • TABLE 147 AUSTRALIA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 154
  • TABLE 148 AUSTRALIA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 155
  • TABLE 149 AUSTRALIA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 155
  • TABLE 150 AUSTRALIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 155
  • TABLE 151 AUSTRALIA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 155
  • TABLE 152 AUSTRALIA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 156
  • TABLE 153 AUSTRALIA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 156
  • TABLE 154 AUSTRALIA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 156
  • TABLE 155 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 157
  • TABLE 156 SINGAPORE SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 157 SINGAPORE SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 158 SINGAPORE SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 157
  • TABLE 159 SINGAPORE PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 160 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 158
  • TABLE 161 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 158
  • TABLE 162 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 158
  • TABLE 163 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
  • TABLE 164 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 159
  • TABLE 165 SINGAPORE SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 159
  • TABLE 166 SINGAPORE ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 160
  • TABLE 167 SINGAPORE DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 160
  • TABLE 168 SINGAPORE PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 160
  • TABLE 169 SINGAPORE CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 161
  • TABLE 170 SINGAPORE RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 161
  • TABLE 171 SINGAPORE REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 161
  • TABLE 172 SINGAPORE OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 161
  • TABLE 173 THAILAND DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 162
  • TABLE 174 THAILAND SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 175 THAILAND SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 176 THAILAND SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 177 THAILAND PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 178 THAILAND DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 163
  • TABLE 179 THAILAND DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 163
  • TABLE 180 THAILAND DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 163
  • TABLE 181 THAILAND DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 164
  • TABLE 182 THAILAND DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 164
  • TABLE 183 THAILAND SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 164
  • TABLE 184 THAILAND ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 165
  • TABLE 185 THAILAND DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 165
  • TABLE 186 THAILAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 165
  • TABLE 187 THAILAND CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 165
  • TABLE 188 THAILAND RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 166
  • TABLE 189 THAILAND REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 166
  • TABLE 190 THAILAND OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 166
  • TABLE 191 INDONESIA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 167
  • TABLE 192 INDONESIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 193 INDONESIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 194 INDONESIA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 195 INDONESIA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 196 INDONESIA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 168
  • TABLE 197 INDONESIA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 168
  • TABLE 198 INDONESIA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 168
  • TABLE 199 INDONESIA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 169
  • TABLE 200 INDONESIA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 169
  • TABLE 201 INDONESIA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 169
  • TABLE 202 INDONESIA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 170
  • TABLE 203 INDONESIA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 170
  • TABLE 204 INDONESIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 170
  • TABLE 205 INDONESIA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 170
  • TABLE 206 INDONESIA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 171
  • TABLE 207 INDONESIA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 171
  • TABLE 208 INDONESIA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 171
  • TABLE 209 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 172
  • TABLE 210 PHILIPPINES SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 172
  • TABLE 211 PHILIPPINES SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 172
  • TABLE 212 PHILIPPINES SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 172
  • TABLE 213 PHILIPPINES PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 214 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 173
  • TABLE 215 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 173
  • TABLE 216 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 173
  • TABLE 217 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 174
  • TABLE 218 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 174
  • TABLE 219 PHILIPPINES SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 174
  • TABLE 220 PHILIPPINES ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 175
  • TABLE 221 PHILIPPINES DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 175
  • TABLE 222 PHILIPPINES PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 175
  • TABLE 223 PHILIPPINES CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 176
  • TABLE 224 PHILIPPINES RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 176
  • TABLE 225 PHILIPPINES REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 176
  • TABLE 226 PHILIPPINES OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 176
  • TABLE 227 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 177
  • TABLE 228 MALAYSIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 229 MALAYSIA SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 230 MALAYSIA SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 231 MALAYSIA PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 178
  • TABLE 232 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 178
  • TABLE 233 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 178
  • TABLE 234 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 178
  • TABLE 235 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 179
  • TABLE 236 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 179
  • TABLE 237 MALAYSIA SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 179
  • TABLE 238 MALAYSIA ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 180
  • TABLE 239 MALAYSIA DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 180
  • TABLE 240 MALAYSIA PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 180
  • TABLE 241 MALAYSIA CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 180
  • TABLE 242 MALAYSIA RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 181
  • TABLE 243 MALAYSIA REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 181
  • TABLE 244 MALAYSIA OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 181
  • TABLE 245 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 182
  • TABLE 246 NEW ZEALAND SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 247 NEW ZEALAND SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 248 NEW ZEALAND SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 249 NEW ZEALAND PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 183
  • TABLE 250 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 183
  • TABLE 251 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 183
  • TABLE 252 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 183
  • TABLE 253 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 184
  • TABLE 254 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 184
  • TABLE 255 NEW ZEALAND SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 184
  • TABLE 256 NEW ZEALAND ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 185
  • TABLE 257 NEW ZEALAND DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 185
  • TABLE 258 NEW ZEALAND PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 185
  • TABLE 259 NEW ZEALAND CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 186
  • TABLE 260 NEW ZEALAND RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 186
  • TABLE 261 NEW ZEALAND REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 186
  • TABLE 262 NEW ZEALAND OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 186
  • TABLE 263 VIETNAM DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 187
  • TABLE 264 VIETNAM SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 265 VIETNAM SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 266 VIETNAM SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 267 VIETNAM PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 268 VIETNAM DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 188
  • TABLE 269 VIETNAM DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 188
  • TABLE 270 VIETNAM DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 188
  • TABLE 271 VIETNAM DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 189
  • TABLE 272 VIETNAM DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 189
  • TABLE 273 VIETNAM SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 189
  • TABLE 274 VIETNAM ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 190
  • TABLE 275 VIETNAM DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 190
  • TABLE 276 VIETNAM PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 190
  • TABLE 277 VIETNAM CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 191
  • TABLE 278 VIETNAM RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 191
  • TABLE 279 VIETNAM REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 191
  • TABLE 280 VIETNAM OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 191
  • TABLE 281 TAIWAN DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 192
  • TABLE 282 TAIWAN SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 283 TAIWAN SOFTWARE IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 284 TAIWAN SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 285 TAIWAN PROFESSIONAL SERVICES IN DRUG MODELING SOFTWARE MARKET, BY TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 286 TAIWAN DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM, 2021-2030 (USD MILLION) 193
  • TABLE 287 TAIWAN DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE, 2021-2030 (USD MILLION) 193
  • TABLE 288 TAIWAN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 193
  • TABLE 289 TAIWAN DRUG MODELING SOFTWARE MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 194
  • TABLE 290 TAIWAN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 194
  • TABLE 291 TAIWAN SUBSCRIPTION BASED IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 194
  • TABLE 292 TAIWAN ONE-TIME LICENSE IN DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL, 2021-2030 (USD MILLION) 195
  • TABLE 293 TAIWAN DRUG MODELING SOFTWARE MARKET, BY END USER, 2021-2030 (USD MILLION) 195
  • TABLE 294 TAIWAN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 195
  • TABLE 295 TAIWAN CONTRACT RESEARCH ORGANIZATIONS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 195
  • TABLE 296 TAIWAN RESEARCH INSTITUTES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 196
  • TABLE 297 TAIWAN REGULATORY AUTHORITIES IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 196
  • TABLE 298 TAIWAN OTHERS IN DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE, 2021-2030 (USD MILLION) 196
  • TABLE 299 REST OF ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET, BY COMPONENTS, 2021-2030 (USD MILLION) 197

LIST OF FIGURES

  • FIGURE 1 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: SEGMENTATION 31
  • FIGURE 2 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: DATA TRIANGULATION 34
  • FIGURE 3 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: DROC ANALYSIS 35
  • FIGURE 4 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: ASIA PACIFIC VS. REGIONAL MARKET ANALYSIS 36
  • FIGURE 5 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: COMPANY RESEARCH ANALYSIS 36
  • FIGURE 6 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: INTERVIEW DEMOGRAPHICS 37
  • FIGURE 7 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: MULTIVARIATE MODELING 38
  • FIGURE 8 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: DBMR MARKET POSITION GRID 39
  • FIGURE 9 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: VENDOR SHARE ANALYSIS 40
  • FIGURE 10 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: MARKET APPLICATION COVERAGE GRID 41
  • FIGURE 11 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: SEGMENTATION 45
  • FIGURE 12 RISING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES, RISING DEMAND FOR NOVEL THERAPIES, AND PRECISION MEDICINE AND INTERVENTION OF AI IN DRUG MODELLING ARE ARE EXPECTED TO DRIVE THE ASIA PACIFIC DRUG MODELING SOFTWARE MARKET GROWTH IN THE FORECAST PERIOD FROM 2023 TO 2030 46
  • FIGURE 13 SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC DRUG MODELING SOFTWARE MARKET IN 2023 & 2030 46
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC DRUG MODELING SOFTWARE MARKET 53
  • FIGURE 15 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS, 2022 63
  • FIGURE 16 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS, 2023-2030 (USD MILLION) 64
  • FIGURE 17 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS, CAGR (2023-2030) 64
  • FIGURE 18 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS, LIFELINE CURVE 65
  • FIGURE 19 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY OPERATING SYSTEM, 2022 71
  • FIGURE 20 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY OPERATING SYSTEM, 2023-2030 (USD MILLION) 72
  • FIGURE 21 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY OPERATING SYSTEM, CAGR (2023-2030) 72
  • FIGURE 22 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY OPERATING SYSTEM, LIFELINE CURVE 73
  • FIGURE 23 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY DEPLOYMENT MODE, 2022 78
  • FIGURE 24 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY DEPLOYMENT MODE, 2023-2030 (USD MILLION) 79
  • FIGURE 25 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY DEPLOYMENT MODE, CAGR (2023-2030) 79
  • FIGURE 26 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY DEPLOYMENT MODE, LIFELINE CURVE 80
  • FIGURE 27 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY ENTERPRISE SIZE, 2022 84
  • FIGURE 28 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY ENTERPRISE SIZE, 2023-2030 (USD MILLION) 85
  • FIGURE 29 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY ENTERPRISE SIZE, CAGR (2023-2030) 85
  • FIGURE 30 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY ENTERPRISE SIZE, LIFELINE CURVE 86
  • FIGURE 31 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY APPLICATION, 2022 90
  • FIGURE 32 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 91
  • FIGURE 33 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY APPLICATION, CAGR (2023-2030) 91
  • FIGURE 34 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY APPLICATION, LIFELINE CURVE 92
  • FIGURE 35 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY PURCHASING MODEL, 2022 101
  • FIGURE 36 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY PURCHASING MODEL, 2023-2030 (USD MILLION) 102
  • FIGURE 37 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY PURCHASING MODEL, CAGR (2023-2030) 102
  • FIGURE 38 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY PURCHASING MODEL, LIFELINE CURVE 103
  • FIGURE 39 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY END USER, 2022 108
  • FIGURE 40 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY END USER, 2023-2030 (USD MILLION) 109
  • FIGURE 41 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY END USER, CAGR (2023-2030) 109
  • FIGURE 42 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: BY END USER, LIFELINE CURVE 110
  • FIGURE 43 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET: SNAPSHOT (2022) 120
  • FIGURE 44 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET: BY COUNTRY (2022) 122
  • FIGURE 45 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET: BY COUNTRY (2023 & 2030) 122
  • FIGURE 46 ASIA-PACIFIC DRUG MODELING SOFTWARE MARKET: BY COMPONENTS (2023-2030) 123
  • FIGURE 47 ASIA PACIFIC DRUG MODELING SOFTWARE MARKET: COMPANY SHARE 2022 (%) 196
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!